This session will allow the participant to (1) Define the current genetic and genomic research in CF; (2) Describe the methodology and recent advances to identify modifiers of CF disease severity; and (3) Summarize the current state of genetic modifiers in CF.
Children's Hospital of Wisconsin
M.D., M.B.A., M.P.H.,
Johns Hopkins Medical Institutions
The Children's Hospital of Philadelphia